-
公开(公告)号:KR1020140049218A
公开(公告)日:2014-04-25
申请号:KR1020120115153
申请日:2012-10-17
Applicant: 원광대학교산학협력단
IPC: A61K36/488 , A61P35/00
CPC classification number: A61K36/488 , A23L33/105 , A23V2002/00 , A23V2200/308
Abstract: The present invention relates to a pharmaceutical composition comprising a Puerariae radix extract for treating and preventing cancer. More specifically, the extract of the present invention not only shows a powerful anticancer activity for colon cancer like CT-26 cells, but also increases generation of MHC II, CD80, CD86, IL-12, CD4, and CD8 which are carcinomatous tissue growth inhibition and immunization modulating substances when co-administered with conventional anticancer medicines such as 5-FU and LV in an animal model experiment of cancer xenograft. Thereby, the extract can be used as a medicine and a functional health food having effects of anti-cancer drugs or anti-cancer adjuvants which is excellent for preventing, suppressing, and treating the cancer.
Abstract translation: 本发明涉及包含用于治疗和预防癌症的葛根提取物的药物组合物。 更具体地说,本发明的提取物不仅显示出对CT-26细胞的结肠癌有强大的抗癌活性,而且增加了癌组织生长的MHC II,CD80,CD86,IL-12,CD4和CD8的产生 在与异种移植物的动物模型实验中共同施用常规抗癌药物如5-FU和LV的抑制和免疫调节物质。 因此,提取物可以用作具有预防,抑制和治疗癌症优异的抗癌药物或抗癌佐剂的作用的药物和功能保健食品。